PharmaEngine: Clinical Trials

12 trials sponsored by PharmaEngine, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

6 completed, 3 recruiting, 2 terminated, 1 unknown. 8 Phase 1, 6 Phase 2, 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 1	8	Completed 3, Recruiting 3, Terminated 2
Phase 2	6	Completed 3, Terminated 2, Unknown 1
Phase 3	1	Completed 1

Follow PharmaEngine: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors PEP08 - Advanced Solid Tumor, Solid Tumors	Phase 1	Recruiting	PharmaEngine	40	2025-08-26	2026-02-13
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients with Advanced or Metastatic Solid Tumors PEP07 - Advanced Solid Tumor, Metastatic Solid Tumor	Phase 1	Recruiting	PharmaEngine	54	2024-03-27	2024-11-07
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer PEP07 - Acute Myeloid Leukemia, Lymphoma, Mantle-Cell	Phase 1	Recruiting	PharmaEngine	32	2023-07-17	2025-07-31
Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors Nanoliposomal Irinotecan - Refractory Solid Tumors	Phase 1	Completed	PharmaEngine	44	2019-03-05	2023-11-18
A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer PEP503, Cisplatin, Radiotherapy - Head and Neck Squamous Cell Carcinoma	Phase 1 / Phase 2	Terminated	PharmaEngine	12	2016-10-11	2022-01-11
A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer PEP503, 5-fluorouracil, capecitabine - Rectal Cancer	Phase 1 / Phase 2	Terminated	PharmaEngine	32	2015-06-01	2022-01-11
NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall NBTXR3, Radiation therapy - Adult Soft Tissue Sarcoma	Phase 2 / Phase 3	Completed	Nanobiotix	180	2015-03-03	2021-04-06
Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy PEP02 - Metastatic Colorectal Cancer	Phase 1	Completed	PharmaEngine	18	2009-06-01	2017-04-06
Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic Cancer PEP02 - Pancreatic Neoplasms	Phase 2	Completed	PharmaEngine	41	2009-01-01	2019-09-06
Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma PEP02, irinotecan, docetaxel - Stomach Neoplasms, Esophageal Neoplasms	Phase 2	Completed	PharmaEngine	135	2007-11-01	2012-03-02
A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors PEP02, 5-FU, LV - Solid Tumor	Phase 1	Completed	PharmaEngine	16	2006-01-01	2016-08-30
Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD) PEP03 - COPD	Phase 2	Unknown	PharmaEngine		2004-09-01	2005-09-22

Conditions studied

Interventions

Countries

Top investigators

Results publications